Literature DB >> 93393

Beta-2-microglobulin, an indicator of renal tubular maturation and dysfunction in the newborn.

A Aperia, U Broberger.   

Abstract

The urinary excretion and proximal tubular reabsorption of beta-2-microglobulin was studied in 17 healthy newborn infants in relation to gestational and post-natal age. The effect of IRDS and non-conjugated hyperbilirubinemia on the tubular reabsorption of the protein was evaluated in 10 IRDS infants and 14 infants with non-conjugated hyperbilirubinemia. The urinary excretion of beta-2-microglobulin was determined under standardized conditions. When GFR was determined, the single injection clearance method was used. The filtered load of beta-2-microglobulin was found to increase with increasing gestational age. This was due to a rise in plasma beta-2-microglobulin concentration as well as to a rise in the GFR. Although the smallest filtered load was recorded in infants with a mean GA of 32.4 weeks, these infants had a lower fractional reabsorption of the protein (88%) than infants with a mean GA of 35.0 weeks or more (98%). In infants with a GA of 35 weeks or more a glomerulo-tubular balance for beta-2-microglobulin apparently was established. In these infants the filtered load of beta-2-microglobulin increased rapidly during the first days of life. This was paralleled by an increase in the reabsorptive capacity for the protein. In infants with IRDS and in infants with non-conjugated hyperbilirubinemia the fractional reabsorption of beta-2-microglobulin was lower than in control infants of a corresponding gestational and postnatal age. This indicates, that in the neonatal period, the proximal tubular transporting capacity is more vulnerable than the glomerular filtration rate in states of hypoxia and hyperbilirubinemia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 93393     DOI: 10.1111/j.1651-2227.1979.tb18436.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  9 in total

1.  Sodium potassium adenosine triphosphatase activity in preterm and term infants and its possible role in sodium homeostasis during maturation.

Authors:  T Bistritzer; M Berkovitch; M J Rappoport; S Evans; S Arieli; M Goldberg; I Tavori; M Aladjem
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-11       Impact factor: 5.747

Review 2.  Antibacterial-induced nephrotoxicity in the newborn.

Authors:  V Fanos; L Cataldi
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

3.  Soluble class I histocompatibility antigens (s-HLA) and beta 2-microglobulin at delivery.

Authors:  A Ferreira; M C García Rodríguez; F Omeñaca; A Jiménez; L M Villar; P Gonzalez-Porqué; G Fontán
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

4.  Renal function of neonates during gentamicin treatment.

Authors:  I Tessin; J Bergmark; K Hiesche; R Jagenburg; B Trollfors
Journal:  Arch Dis Child       Date:  1982-10       Impact factor: 3.791

Review 5.  Antibiotics in neonatal infections: a review.

Authors:  V Fanos; A Dall'Agnola
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

6.  Assessment of tubular function in neonates using urinary beta 2-microglobulin.

Authors:  H Tsukahara; M Yoshimoto; M Saito; T Sakaguchi; I Mitsuyoshi; S Hayashi; K Nakamura; K Kikuchi; M Sudo
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

7.  The cerebrospinal fluid and plasma concentrations of gamma-trace and beta2-microglobulin at various ages and in neurological disorders.

Authors:  H Löfberg; A O Grubb; T Sveger; J E Olsson
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

8.  Microproteins in amniotic fluid as an index of changes in fetal renal function during development.

Authors:  R Burghard; R Pallacks; N Gordjani; J U Leititis; B J Hackelöer; M Brandis
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

9.  Tubular immaturity causes erythropoietin-deficiency anemia of prematurity in preterm neonates.

Authors:  Nariaki Asada
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.